Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seock-Ah Im

Showing results (41-50 of 567) with videos related to

Pageof 57
Sort By:
Molecular Cancer Therapeutics|March 19, 2008
Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cellsHwang-Phill Kim, Sae-Won Han, Sung-Hak Kim, et al.
Cancer Science|April 2, 2011
Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteinsKyung-Hun Lee, Ju-Hee Lee, Sae-Won Han, et al.
Journal of Breast Cancer|January 24, 2014
Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of ResponseHo-Chang Lee, Hyoungsuk Ko, Hyesil Seol, et al.
The Oncologist|May 30, 2014
Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRASandra M Swain, Young-Hyuck Im, Seock-Ah Im, et al.
International Journal of Clinical Pharmacy|July 2, 2016
Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unitJi-Min Han, Young-Mi Ah, Sung Yun Suh, et al.
Scientific Reports|July 29, 2020
Homologous repair deficiency score for identifying breast cancers with defective DNA damage responseAhrum Min, Kwangsoo Kim, Kyeonghun Jeong, et al.
Anticancer Research|April 1, 2009
Neoadjuvant chemotherapy followed by limited surgery in a mouse model of head and neck cancerJae Jin Lee, Jeong-Hun Hah, Seock-Ah Im, et al.
Radiology|April 18, 2014
Breast cancer: early prediction of response to neoadjuvant chemotherapy using parametric response maps for MR imagingNariya Cho, Seock-Ah Im, In-Ae Park, et al.
Oncology|June 14, 2014
Low adherence to upfront and extended adjuvant letrozole therapy among early breast cancer patients in a clinical practice settingHye-Suk Lee, Ju-Yeun Lee, Young-Mi Ah, et al.
American Journal of Clinical Oncology|March 24, 2010
Clinical outcomes of sorafenib treatment in patients with metastatic hepatocellular carcinoma who had been previously treated with fluoropyrimidine plus platinum-based chemotherapyJi-Won Kim, Jeong-Ok Lee, Sae-Won Han, et al.
Pageof 57

Showing results (41-50 of 567) with videos related to

Sort By:
Pageof 57
Molecular Cancer Therapeutics|March 19, 2008
Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cellsHwang-Phill Kim, Sae-Won Han, Sung-Hak Kim, et al.
Cancer Science|April 2, 2011
Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteinsKyung-Hun Lee, Ju-Hee Lee, Sae-Won Han, et al.
Journal of Breast Cancer|January 24, 2014
Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of ResponseHo-Chang Lee, Hyoungsuk Ko, Hyesil Seol, et al.
The Oncologist|May 30, 2014
Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRASandra M Swain, Young-Hyuck Im, Seock-Ah Im, et al.
International Journal of Clinical Pharmacy|July 2, 2016
Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unitJi-Min Han, Young-Mi Ah, Sung Yun Suh, et al.
Scientific Reports|July 29, 2020
Homologous repair deficiency score for identifying breast cancers with defective DNA damage responseAhrum Min, Kwangsoo Kim, Kyeonghun Jeong, et al.
Anticancer Research|April 1, 2009
Neoadjuvant chemotherapy followed by limited surgery in a mouse model of head and neck cancerJae Jin Lee, Jeong-Hun Hah, Seock-Ah Im, et al.
Radiology|April 18, 2014
Breast cancer: early prediction of response to neoadjuvant chemotherapy using parametric response maps for MR imagingNariya Cho, Seock-Ah Im, In-Ae Park, et al.
Oncology|June 14, 2014
Low adherence to upfront and extended adjuvant letrozole therapy among early breast cancer patients in a clinical practice settingHye-Suk Lee, Ju-Yeun Lee, Young-Mi Ah, et al.
American Journal of Clinical Oncology|March 24, 2010
Clinical outcomes of sorafenib treatment in patients with metastatic hepatocellular carcinoma who had been previously treated with fluoropyrimidine plus platinum-based chemotherapyJi-Won Kim, Jeong-Ok Lee, Sae-Won Han, et al.
Pageof 57